Zacks Research Predicts Lower Earnings for Core Laboratories

Core Laboratories Inc. (NYSE:CLB) – Analysts at Zacks Research decreased their FY2027 EPS estimates for shares of Core Laboratories in a research note issued to investors on Friday, July 17th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings per share of $0.80 for the year, down from their prior forecast of $0.82. The consensus estimate for Core Laboratories’ current full-year earnings is $0.53 per share.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The business had revenue of $121.80 million for the quarter, compared to analysts’ expectations of $122.99 million. During the same quarter in the prior year, the company earned $0.14 earnings per share. The business’s revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.

A number of other research firms have also weighed in on CLB. Weiss Ratings lowered Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, June 24th. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Core Laboratories has a consensus rating of “Reduce”.

Core Laboratories Stock Performance

Shares of CLB opened at $11.48 on Monday. The company has a quick ratio of 1.50, a current ratio of 2.05 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average price is $12.44 and its 200-day moving average price is $15.60. Core Laboratories has a 52 week low of $9.72 and a 52 week high of $20.36. The stock has a market cap of $529.46 million, a P/E ratio of 17.67, a P/E/G ratio of 2.70 and a beta of 1.00.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Monday, May 11th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, May 11th. This represents a $0.04 annualized dividend and a yield of 0.3%. Core Laboratories’s payout ratio is 6.15%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. increased its position in shares of Core Laboratories by 185.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 845,251 shares of the oil and gas company’s stock valued at $13,549,000 after acquiring an additional 548,657 shares in the last quarter. Disciplined Growth Investors Inc. MN lifted its position in Core Laboratories by 9.7% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after acquiring an additional 528,976 shares in the last quarter. MAC Alpha Capital Management LP purchased a new stake in Core Laboratories during the 4th quarter valued at $5,016,000. Heartland Advisors Inc. bought a new stake in shares of Core Laboratories in the 1st quarter worth $2,518,000. Finally, Renaissance Technologies LLC raised its stake in shares of Core Laboratories by 436.6% in the fourth quarter. Renaissance Technologies LLC now owns 183,400 shares of the oil and gas company’s stock worth $2,940,000 after purchasing an additional 149,219 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.